UNSPSC 85445701: The diagnosis of cardiac-stimulant glycosides and drugs of similar action

In this classification, this covers the group of activities that yields a diagnosis of cardiac-stimulant glycosides and drugs of similar action. Cardiac-stimulant glycosides and drugs of similar action is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y52.0.

UNSPSC 85445701, The diagnosis of cardiac-stimulant glycosides and drugs of similar action, is a Commodity code showing a significant mismatch between its nominal pharmaceutical scope and the recent state and local contract opportunities tagged under it. The three most recent solicitations posted under this code involve diagnostic imaging systems (San Mateo Medical Center's PACS implementation), special education contracted services (Birdville Independent School District), and temporary health professional staffing (Santa Clara County Health System) — none of which involve cardiac-stimulant glycosides or pharmaceutical diagnosis. The code shows little relevant recent activity in its actual domain; the opportunities reflect a classification error rather than legitimate state and local procurement of cardiac drugs or related diagnostics.

Given the absence of genuine opportunities under this code's stated scope, business development professionals should treat this code as inactive for pharmaceutical procurement purposes. The mismatch suggests that state and local procurement offices may be applying this UNSPSC code inconsistently or incorrectly. Monitor for corrected filings and direct market outreach to public health systems, state pharmacy programs, and county health departments separately, rather than relying on opportunities tagged to this code.